Catalyst

Slingshot members are tracking this event:

Silence Therapeutics (SLN) Sues Alnylam (ALNY) on dispute over commercialization of ONPATTRO (patisiran) in the EU

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ALNY

100%
IONS

100%
SLN.L

100%
AKCA

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 11, 2018
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Onpattro, Patisiran